PMC:7594251 / 81-354 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":154,"end":164},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"isease models at the molecular level is vital for drug development in order to improve treatment and prevent a wide range of human pathologies. Microbial infections are still a major challenge because pathogens rapidly and continually evolve developing drug resistance. Can"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T32708","span":{"begin":109,"end":110},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T17685","span":{"begin":125,"end":130},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T97528","span":{"begin":175,"end":176},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"isease models at the molecular level is vital for drug development in order to improve treatment and prevent a wide range of human pathologies. Microbial infections are still a major challenge because pathogens rapidly and continually evolve developing drug resistance. Can"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":50,"end":54},"obj":"Chemical"},{"id":"T3","span":{"begin":253,"end":257},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"isease models at the molecular level is vital for drug development in order to improve treatment and prevent a wide range of human pathologies. Microbial infections are still a major challenge because pathogens rapidly and continually evolve developing drug resistance. Can"}

{"project":"LitCovid-PubTator","denotations":[{"id":"7","span":{"begin":125,"end":130},"obj":"Species"},{"id":"9","span":{"begin":154,"end":164},"obj":"Disease"}],"attributes":[{"id":"A7","pred":"tao:has_database_id","subj":"7","obj":"Tax:9606"},{"id":"A9","pred":"tao:has_database_id","subj":"9","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"isease models at the molecular level is vital for drug development in order to improve treatment and prevent a wide range of human pathologies. Microbial infections are still a major challenge because pathogens rapidly and continually evolve developing drug resistance. Can"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T77349","span":{"begin":253,"end":268},"obj":"http://purl.obolibrary.org/obo/GO_0042493"}],"text":"isease models at the molecular level is vital for drug development in order to improve treatment and prevent a wide range of human pathologies. Microbial infections are still a major challenge because pathogens rapidly and continually evolve developing drug resistance. Can"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":253,"end":268},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0020174"}],"text":"isease models at the molecular level is vital for drug development in order to improve treatment and prevent a wide range of human pathologies. Microbial infections are still a major challenge because pathogens rapidly and continually evolve developing drug resistance. Can"}

{"project":"LitCovid-sentences","denotations":[{"id":"T4","span":{"begin":144,"end":269},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"isease models at the molecular level is vital for drug development in order to improve treatment and prevent a wide range of human pathologies. Microbial infections are still a major challenge because pathogens rapidly and continually evolve developing drug resistance. Can"}